Health Condition 1: N72- Inflammatory disease of cervix uteri
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Between 25 and 65 years age 2.Irrespective of marital status, with a history of sexual cohabitation, 3.Complaints of vaginal and blood mixed discharge, foul-smell in discharge, postcoital bleeding, postmenopausal bleeding, Intermenstrual bleeding, lower abdominal pain 4.showing lesion on cervix after visual inspection with acetic acid application and 5.Abnormal Pap smear report: Atypical squamous cells of undetermined significance (ASCUS), atypical squamous cells, cannot exclude HSIL (ASC-H), low-grade intraepithelial lesion (LSIL), high-grade intraepithelial, lesion (HSIL) and cancerous (Ca) on Pap test WAS considered as positive.
Exclusion criteria
Exclusion criteria: 1. Lactating and pregnant women 2 Active vaginal bleeding 3. Frank growth on cervix 4. Post-hysterectomy patients 5. Those who are not sexually active 6. Women who have undergone prior treatment for cervical intraepithelial neoplasia (CIN) and cervical cancer. • Women below 25 years old and above the age of 65 years • Individuals with previous history of any systemic malignancies or any other major systemic terminal disease • Individuals who will refuse to participate or give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary outcome will measure the level of agreement and ? (kappa) statistic between both devices. The agreement on colposcopy findings between the two methods will be determined using Cohen’s Kappa coefficient.Timepoint: at 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| our secondary outcome measure will be level of agreement between 2 devices in terms of its performanceTimepoint: at baseline | — |
Countries
India
Contacts
Jawaharlal Nehru Medical College